ArticleFrontiers in sports and active living2026
Heart rate variability-guided endurance training: evaluating strengths, weaknesses, opportunities, and threats for load prescription and adjustment.
Article in Frontiers in sports and active living, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart rate variability (HRV) has been used to guide individualized endurance training prescription. By supporting training adjustments according to recovery status, HRV-guided approaches may improve the alignment between training load and physiological readiness. However, the practical value depends on the decision framework used to translate HRV measurements into training prescriptions. This paper applies a Strengths, Weaknesses, Opportunities, and Threats (SWOT) framework to critically evaluate the practical limitations of HRV-guided training regulation. Strengths include a well-established physiological rationale, evidence from controlled studies, expanding application across broader populations, and methodological advances in monitoring supported by wearable technologies. Weaknesses include the limited specificity of HRV as a global marker of cardiac autonomic modulation, the absence of standardized multimodal frameworks, and the persistent gap between research-based monitoring concepts and their implementation in practice. Opportunities lie in the development of transparent multivariate decision architectures, refinement of baseline and progression logic, and data-driven approaches to support individualized, context-aware training adjustments. Threats arise from rule-based decision frameworks that may inadequately capture the complexity and context-dependency of physiological adaptation, limited replication in real-world training environment, and growing dependence on proprietary metrics whose underlying algorithms lack transparency and may oversimplify training decisions. Overall, the primary limitation of HRV-guided endurance training is no longer the availability of physiological data, but the lack of transparent and physiologically grounded decision frameworks that define how HRV-derived signals should be interpreted, weighted, and translated into valid and actionable training prescriptions. Addressing this gap represents a critical step toward the development of adaptive training frameworks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.